# US 2015/0177348 A1 · Biosensor, palm-sized device and method based on magnetic resonance relaxometry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0177348 A1
- Document ID: US20150177348A1
- Status: Published application
- Kind: A1
- Application number: 14/497,233
- Filed: 2014-09-25
- Published: 2015-06-25
- Earliest claimed: 2011-02-28
- Assignees: Lan CHEN; Massachusetts Institute of Technology
- Applicants: Massachusetts Institute of Technology
- Inventors: Weng Kung Peng; Jongyoon Han
- Web page: https://patentgrep.com/patent/US20150177348A1

## CPC

- G01R 33/448: {Relaxometry, i.e. quantification of relaxation times or spin density (G01R33/50 takes precedence)}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- G01N 24/08: by using nuclear magnetic resonance (G01N24/12 takes precedence)
- G01R 33/302: {Miniaturized sample handling arrangements for sampling small quantities, e.g. flow-through microfluidic NMR chips}
- G01R 33/383: using permanent magnets
- G01R 33/4828: {Resolving the MR signals of different chemical species, e.g. water-fat imaging}
- G01R 33/50: based on the determination of relaxation times {, e.g. T1 measurement by IR sequences; T2 measurement by multiple-echo sequences}
- G01R 33/543: {Control of the operation of the MR system, e.g. setting of acquisition parameters prior to or during MR data acquisition, dynamic shimming, use of one or more scout images for scan plane prescription (G01R33/546 takes precedence)}
- G01R 33/546: {Interface between the MR system and the user, e.g. for controlling the operation of the MR system or for the design of pulse sequences}
- G01R 33/3808: {Magnet assemblies for single-sided MR wherein the magnet assembly is located on one side of a subject only; Magnet assemblies for inside-out MR, e.g. for MR in a borehole or in a blood vessel, or magnet assemblies for fringe-field MR}
- G01R 33/465: applied to biological material, e.g. in vitro testing
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

In accordance with one aspect of this disclosure, there is provided a device for performing magnetic resonance relaxometry. The device comprises a radio-frequency spectrometer comprising at least one field-programmable gate array chip; a power amplifier electrically connected with the radio-frequency spectrometer and amplifying an electrical output of the radio-frequency spectrometer, thereby producing an amplified electrical signal comprising between about 0.1 Watts and about 10 Watts power; a duplexer configured to isolate the radio-frequency spectrometer from the amplified electrical signal during a receiving mode of the device; a radio-frequency detection probe configured to transmit radio-frequency electromagnetic radiation to excite nuclei under resonance during a transmission mode of the device, the radio-frequency detection probe comprising a detection coil comprising an inner diameter of less than about 1 millimeter; and at least one magnet supplying an external magnetic field to a detection region of the radio-frequency detection probe, the external magnetic field being less than about 3 Tesla.

## Claims

### Claim 1

A device for performing magnetic resonance relaxometry, the device comprising:
a radio-frequency spectrometer comprising at least one fieldprogrammable gate array chip;
a power amplifier electrically connected with the radio-frequency spectrometer and amplifying an electrical output of the radio-frequency spectrometer, thereby producing an amplified electrical signal comprising between about 0.1 Watts and about 10 Watts power;
a duplexer configured to isolate the radio-frequency spectrometer from the amplified electrical signal during a receiving mode of the device;
a radio-frequency detection probe configured to transmit radiofrequency electromagnetic radiation to excite nuclei under resonance during a transmission mode of the device, the radio-frequency detection probe comprising a detection coil comprising an inner diameter of less than about 1 millimeter; and
at least one magnet supplying an external magnetic field to a detection region of the radio-frequency detection probe, the external magnetic field being less than about 3 Tesla.

### Claim 2 (depends on 1)

A device according to claim 1, wherein the at least one magnet comprises at least two permanent magnets separated by a gap of less than about 5 millimeters.

### Claim 3 (depends on 1)

A device according to claim 1, wherein the device weighs less than about 0.5 kilograms.

### Claim 4 (depends on 1)

A device according to claim 1, wherein the radio-frequency spectrometer, power amplifier and the at least one magnet are mounted on a single circuit board of less than about 500 square centimeters size.

### Claim 5 (depends on 1)

A device according to claim 1, wherein the radio-frequency spectrometer comprises a pulse programmer, a direct digital synthesis module, the transmitter and a receiver.

### Claim 6 (depends on 1)

A device according to claim 1, wherein the power amplifier comprises at least one surface mount power amplifier module and is mounted on a single circuit board of less than about 20 square centimeter area.

### Claim 7 (depends on 1)

A device according to claim 1, wherein the at least one magnet fits within a volume of less than about 30 cubic centimeters.

### Claim 8 (depends on 1)

A device according to claim 1, wherein the duplexer comprises a passive duplexer without a quarter wavelength transmission cable, the passive duplexer comprising: a chip inductor in parallel with a fixed capacitor that is in series with a pair of crossed diodes; a trimmer capacitor in series with the parallel combination of the chip inductor, fixed capacitor and pair of crossed diodes; and at least one surface mount radio frequency switch diode.

### Claim 9 (depends on 1)

A device according to claim 1, wherein the device is configured to receive a centrifuge tube, which same centrifuge tube is configured to be received in a centrifuge.

### Claim 10 (depends on 1)

A device according to claim 1, further comprising a centrifuge tube, at least a portion of the centrifuge tube being inserted into the detection region of the radio-frequency detection probe.

### Claim 11 (depends on 10)

A device according to claim 10, wherein the centrifuge tube comprises an outside diameter of less than about 1 millimeter, the centrifuge tube comprising a blood sample including blood from an animal body.

### Claim 12 (depends on 1)

A device according to claim 1, wherein the device is configured to perform at least one of Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI).

### Claim 13 (depends on 1)

A device according to claim 1, further comprising a sample comprising a micro-organism, at least a portion of the sample being inserted into the detection region of the radio-frequency detection probe.

### Claim 14 (depends on 1)

A device according to claim 1, further comprising an item to be imaged, at least a portion of the item to be imaged being inserted into the detection region of the radio-frequency detection probe.

### Claim 15 (depends on 1)

A device according to claim 1, further comprising a biological sample, at least a portion of the biological sample being inserted into the detection region of the radio-frequency detection probe.

### Claim 16 (depends on 15)

A device according to claim 15, wherein the biological sample is capable of producing an indication of a stress level on a biological organism through magnetic resonance.

### Claim 17 (depends on 15)

A device according to claim 15, wherein the biological sample comprises a biomarker of a disease, the biomarker being detectable by magnetic resonance.

### Claim 18

A method of determining an infection level of cells in blood from an animal body using magnetic resonance relaxometry, the method comprising:
concentrating at least a portion of a blood sample comprising the blood from the animal body thereby producing concentrated red blood cells;
inserting the concentrated red blood cells within a detection coil of a magnetic resonance relaxometry device; and
determining an infection level of the cells in the blood based at least in part on a transverse relaxation rate of the concentrated red blood cells in the magnetic resonance relaxometry device.

### Claim 19 (depends on 18)

A method according to claim 18, wherein the determining the infection level of the cells is based at least in part on a change in a transverse relaxation rate of the concentrated red blood cells relative to a predetermined standard for transverse relaxation rate for blood that is not infected with a disease.

### Claim 20 (depends on 18)

A method according to claim 18, wherein concentrating the blood sample comprises centrifuging the blood sample in a centrifuge tube, and wherein the same centrifuge tube used in the centrifuging of the blood sample is used in the inserting of the concentrated red blood cells within the detection coil of the magnetic resonance relaxometry device.

### Claim 21 (depends on 18)

A method according to claim 18, wherein the method comprises determining infection level of red blood cells infected with hemoglobin-feeding parasites in blood from a human body.

### Claim 22 (depends on 21)

A method according to claim 21, wherein the method comprises determining infection level for at least one of red blood cells infected with plasmodium falciparum, plasmodium malariae, plasmodium vivax and plasmodium ovale in the blood from the human body.

### Claim 23 (depends on 18)

A method according to claim 18, wherein an external magnetic field applied to the concentrated red blood cells by the magnetic resonance relaxometry device is less than about 3 Tesla.

### Claim 24 (depends on 18)

A method according to claim 18, wherein the determining the infection level is perfonned without chemical labeling of the cells and without immunomagnetic labeling of the cells.

### Claim 25 (depends on 18)

A method according to claim 18, wherein a detection region of the magnetic resonance relaxometry device comprises a volume covering less than about 1 μl of the concentrated red blood cells.

### Claim 26 (depends on 18)

A method according to claim 18, wherein the detection coil comprises an inner diameter of less than about 1 millimeter.

### Claim 27 (depends on 18)

A method according to claim 18, wherein the determining the infection level of the cells is performed within about one minute from the inserting the concentrated red blood cells within the detection coil.

### Claim 28 (depends on 18)

A method according to claim 18, wherein determining the infection level comprises determining a magnetic susceptibility index of the cells.

### Claim 29 (depends on 28)

A method according to claim 28, wherein the magnetic susceptibility index is based at least in part on the transverse relaxation rate and is related to parasitemia level and stage of infection for the cells in the blood from the animal body.

### Claim 30 (depends on 18)

A method according to claim 18, wherein the method comprises performing at least one of Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI).
